News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
812,598 Results
Type
Article (77366)
Company Profile (540)
Press Release (734692)
Section
Business (226382)
Career Advice (3777)
Deals (39022)
Drug Delivery (127)
Drug Development (89620)
Employer Resources (189)
FDA (17876)
Job Trends (16861)
News (386351)
Policy (38431)
Tag
Academia (2974)
Alliances (55564)
Alzheimer's disease (1425)
Approvals (17828)
Artificial intelligence (239)
Bankruptcy (390)
Best Places to Work (12606)
Biotechnology (383)
Breast cancer (243)
Cancer (1844)
Cardiovascular disease (148)
Career advice (3212)
CAR-T (140)
Cell therapy (403)
Clinical research (71637)
Collaboration (721)
Compensation (382)
COVID-19 (2837)
C-suite (175)
Data (1675)
Diabetes (233)
Diagnostics (6804)
Earnings (91805)
Employer resources (163)
Events (126827)
Executive appointments (602)
FDA (18829)
Funding (651)
Gene therapy (285)
GLP-1 (771)
Government (5075)
Healthcare (20798)
Infectious disease (2962)
Inflammatory bowel disease (135)
Interviews (733)
IPO (17639)
Job creations (4757)
Job search strategy (2627)
Layoffs (516)
Legal (9580)
Lung cancer (276)
Manufacturing (266)
Medical device (14451)
Medtech (14456)
Mergers & acquisitions (21756)
Metabolic disorders (630)
Neuroscience (1882)
NextGen: Class of 2025 (7576)
Non-profit (5073)
Northern California (2148)
Obesity (354)
Opinion (261)
Patents (173)
People (63901)
Phase I (22220)
Phase II (31223)
Phase III (23414)
Pipeline (743)
Postmarket research (3307)
Preclinical (9861)
Radiopharmaceuticals (263)
Rare diseases (363)
Real estate (7068)
Regulatory (25681)
Research institute (2639)
Resumes & cover letters (597)
Southern California (1853)
Startups (4157)
United States (19692)
Vaccines (719)
Weight loss (266)
Date
Today (11)
Last 7 days (641)
Last 30 days (2733)
Last 365 days (36904)
2025 (4819)
2024 (37743)
2023 (42519)
2022 (53866)
2021 (58658)
2020 (57598)
2019 (51267)
2018 (39036)
2017 (36608)
2016 (37459)
2015 (43517)
2014 (38305)
2013 (34661)
2012 (36803)
2011 (36791)
2010 (36600)
Location
Africa (1177)
Arizona (245)
Asia (47451)
Australia (8273)
California (4991)
Canada (1750)
China (418)
Colorado (226)
Connecticut (253)
Europe (107921)
Florida (711)
Georgia (177)
Illinois (535)
Indiana (280)
Maryland (803)
Massachusetts (3883)
Michigan (223)
Minnesota (358)
New Jersey (1415)
New York (1415)
North Carolina (963)
Northern California (2148)
Ohio (185)
Pennsylvania (1129)
South America (1561)
Southern California (1853)
Texas (740)
Utah (152)
Washington State (501)
812,598 Results for "foundation for the national institutes of health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Business
The Foundation for the National Institutes of Health Appoints Love Collins, III to Lead Advancement and Development
The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.
May 13, 2024
·
3 min read
Business
The Foundation for the National Institutes of Health Appoints James W. Down and Perry Steiner to Its Board of Directors
The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.
May 29, 2024
·
3 min read
BioCapital
The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
The Foundation for the National Institutes of Health announces the launch of a public-private partnership to build the largest data source for amyotrophic lateral sclerosis and expedite the identification of biomarkers and clinical outcome assessments that would allow earlier diagnosis and accelerated drug development for people living with the disease.
May 21, 2024
·
6 min read
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Press Releases
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
January 30, 2025
·
4 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies in its suspension platform for several programs under the Foundation for the National Institutes of Health Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium.
February 28, 2024
·
3 min read
1 of 81,260
Next
